Open AccessPossible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study
Author(s) -
Tofan Widya Utami,
Andrijono Andrijono,
Andi Darma Putra,
Junita Indarti,
Gert Jan Fleuren,
Ekaterina S. Jordanova,
Inas R. Humairah,
Ahmad Utomo
Publication year - 2022
Publication title -
clinical and experimental vaccine research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.958
H-Index - 11
eISSN - 2287-366X
pISSN - 2287-3651
DOI - 10.7774/cevr.2022.11.2.141
Subject(s) - medicine , genotyping , genotype , cervical cancer , population , hpv infection , cervix , hpv vaccines , human papillomavirus , gynecology , virology , cancer , oncology , environmental health , biology , biochemistry , gene
Human papillomavirus (HPV) genotype and age distribution of HPV infection were crucial for the national vaccination and screening program planning. However, there was a limited study providing these data in the normal cervix population. This study aimed to explore the HPV genotypes profile of women with clinically normal cervix based on Visual Inspection of Acetic Acid (VIA) test.